Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial assessing Triptorelin to prevent chemotherapy-induced early menopause in premenopausal women with surgically removed stage I–III breast cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triptorelin (triptorelin)

Snippet

Sponsor: Gruppo Italiano Mammella (GIM) | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED